Temperature Maintenance of Biopharmaceuticals5th -6th June 2013, Boston, USA
With consistent pressure to reduce costs across the board, product distribution and temperature maintenance professionals are faced with the biggest challenge, especially considering the increasingly tightly regulated and highly technologically driven environment.
After a fantastic launch year in 2012, Temperature Maintenance of Biopharmaceuticals returns; bringing together the local community to discuss, benchmark and share ideas on cost efficient and innovative ways to ensure compliance to product temperature profiles during distribution.
With constant change in FDA regulations and the increasing awareness surrounding ambient temperature maintenance regulations to coincide with cold storage regulations; Remaining on the forefront of new information is becoming essential to continue growth, compliance and cost-effectiveness within the pharmaceutical industry.
Arena International launches the 2nd Annual Temperature Maintenance of Biopharmaceuticals Boston Conference
With the number of biologic drugs being produced rising year-on-year, the issue of temperature control within the supply chain is of growing importance. This year’s agenda, with participation from Merck, Genzyme, Pfizer and the FDA will explore the current challenges facing the industry, and will present itself as a unique platform for senior industry representatives to discuss and develop solutions to issues within temperature maintenance; including regulatory compliance, controlled ...
After the success of last year’s launch event, Arena International’s 2nd Annual Temperature Maintenance of Biopharmaceuticals conference will provide the perfect platform for attendees to discuss the latest trends and challenges within both Cold Chain and Ambient Temperature distribution.
This unique event will offer an unparalleled opportunity for networking and knowledge-sharing with key industry professionals from the temperature maintenance industry. This conference will bring together senior level representatives from the industry and should be attend by those in pharmaceutical and biotechnology companies with the following job titles: